(FY)Jun 30, 2023 | (FY)Jun 30, 2022 | |
---|---|---|
Operating cash flow (direct method) | ||
Cash income from operating activities | ||
Cash paid | -21.61%-1.3M | -1.07M |
Payments to suppliers for goods and services | -21.61%-1.3M | ---1.07M |
Operating cash flow | -21.61%-1.3M | ---1.07M |
Investing cash flow | ||
Cash flow from continuing investing activities | -7.46%-2.56M | -2.39M |
Capital expenditure reported | -12.71%-2.55M | ---2.26M |
Net PPE purchase and sale | 88.08%-14.83K | ---124.42K |
Cash from discontinued investing activities | ||
Investing cash flow | -7.46%-2.56M | ---2.39M |
Financing cash flow | ||
Cash flow from continuing financing activities | -12.41%4.4M | 5.02M |
Net issuance payments of debt | ---- | ---197.64K |
Net common stock issuance | -15.72%4.4M | --5.22M |
Cash from discontinued financing activities | ||
Financing cash flow | -12.41%4.4M | --5.02M |
Net cash flow | ||
Beginning cash position | 7,009.95%1.59M | --22.31K |
Current changes in cash | -66.06%530.82K | --1.56M |
End cash Position | 33.46%2.12M | --1.59M |
Free cash from | -11.85%-3.87M | ---3.46M |
Accounting Standards | US-GAAP | US-GAAP |
No Data